ICON PLC (ICLR) Stock Price & Overview

NASDAQ:ICLR • IE0005711209

Current stock price

113.06 USD
+2.69 (+2.44%)
At close:
112.932 USD
-0.13 (-0.11%)
After Hours:

The current stock price of ICLR is 113.06 USD. Today ICLR is up by 2.44%. In the past month the price increased by 15.83%. In the past year, price decreased by -18.85%.

ICLR Key Statistics

52-Week Range66.57 - 211
Current ICLR stock price positioned within its 52-week range.
1-Month Range95.75 - 115.625
Current ICLR stock price positioned within its 1-month range.
Market Cap
8.633B
P/E
8.57
Fwd P/E
8.90
EPS (TTM)
13.19
Dividend Yield
N/A

ICLR Stock Performance

Today
+2.44%
1 Week
+5.51%
1 Month
+15.83%
3 Months
-38.09%
Longer-term
6 Months -38.91%
1 Year -18.85%
2 Years -62.05%
3 Years -41.33%
5 Years -47.89%
10 Years +67.30%

ICLR Stock Chart

ICON PLC / ICLR Daily stock chart

ICLR Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ICLR. When comparing the yearly performance of all stocks, ICLR is a bad performer in the overall market: 89.34% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ICLR Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ICLR. ICLR has an average financial health and profitability rating.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ICLR Earnings

On October 22, 2025 ICLR reported an EPS of 3.31 and a revenue of 2.04B. The company missed EPS expectations (-1.21% surprise) and beat revenue expectations (1.03% surprise).

Next Earnings DateApr 29, 2026
Last Earnings DateOct 22, 2025
PeriodQ3 / 2025
EPS Reported$3.31
Revenue Reported2.043B
EPS Surprise -1.21%
Revenue Surprise 1.03%

ICLR Forecast & Estimates

24 analysts have analysed ICLR and the average price target is 152.55 USD. This implies a price increase of 34.93% is expected in the next year compared to the current price of 113.06.

For the next year, analysts expect an EPS growth of -5.55% and a revenue growth -2.68% for ICLR


Analysts
Analysts75
Price Target152.55 (34.93%)
EPS Next Y-5.55%
Revenue Next Year-2.68%

ICLR Groups

Sector & Classification

Index Membership

ICLR Financial Highlights

Over the last trailing twelve months ICLR reported a non-GAAP Earnings per Share(EPS) of 13.19. The EPS decreased by -5.99% compared to the year before.


Income Statements
Revenue(TTM)8.10B
Net Income(TTM)599.48M
Industry RankSector Rank
PM (TTM) 7.4%
ROA 3.63%
ROE 6.42%
Debt/Equity 0.31
Chartmill High Growth Momentum
EPS Q2Q%-1.19%
Sales Q2Q%0.63%
EPS 1Y (TTM)-5.99%
Revenue 1Y (TTM)-2.46%

ICLR Ownership

Ownership
Inst Owners110.05%
Shares76.36M
Float75.76M
Ins Owners0.66%
Short Float %3.82%
Short Ratio1.43

About ICLR

Company Profile

ICLR logo image ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 39,800 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Company Info

IPO: 1998-05-15

ICON PLC

South County Business Park, LEOPARDSTOWN, Dublin 18

DUBLIN DUBLIN 00000 IE

CEO: Steve Cutler

Employees: 39800

ICLR Company Website

ICLR Investor Relations

Phone: 35312912000

ICON PLC / ICLR FAQ

Can you describe the business of ICON PLC?

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The company is headquartered in Dublin, Dublin and currently employs 39,800 full-time employees. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.


What is the current price of ICLR stock?

The current stock price of ICLR is 113.06 USD. The price increased by 2.44% in the last trading session.


Does ICLR stock pay dividends?

ICLR does not pay a dividend.


How is the ChartMill rating for ICON PLC?

ICLR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is ICON PLC (ICLR) stock traded?

ICLR stock is listed on the Nasdaq exchange.


What is the outstanding short interest for ICON PLC?

The outstanding short interest for ICON PLC (ICLR) is 3.82% of its float.